Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015

Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015

Summary

GlobalData’s “Glucose monitoring systems Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global glucose monitoring systems market. The report identifies the key trends shaping and driving the dynamism in the global glucose monitoring systems market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global glucose monitoring systems sector.

Scope

- Annualized global glucose monitoring systems market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global glucose monitoring systems market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global glucose monitoring systems market in the long run.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Key companies covered include F. Hoffmann-La Roche Ltd, LifeScan (Johnson & Johnson), Bayer Healthcare and Abbott Laboratories
- Major marketed and key upcoming pipeline products have been covered
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global glucose monitoring systems market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global glucose monitoring systems market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

1 Table Of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Executive Summary 8
3 Global Glucose Monitoring Systems Market : Market Characterization 9
3.1 Overview 9
3.2 Glucose Monitoring Systems Market, Revenue ($ m), 2000 – 2008 9
3.3 Glucose Monitoring Systems Market, Revenue ($ m), 2008 – 2015 11
3.4 Glucose Monitoring Systems: Market Dynamics 12
3.4.1 Market Drivers 12
3.4.1.1 Increasing Prevalence of Diabetes to Boost Sales 12
3.4.1.2 Introduction of New Generation Devices to Drive the Glucose Monitoring Market 15
3.4.1.3 Home Healthcare to Boost Glucose Monitoring Market 15
3.4.1.4 Increasing Ageing and Obese Population Contributing to Diabetes Epidemic 15
3.4.1.5 Increasing Awareness about Diabetes, its Control and Related Complications to Drive the Market in Future 15
3.4.2 Market Restraints 16
3.4.2.1 High Cost and Reimbursement Hassles- a Growth Limiting Factor 16
3.4.2.2 Low Market Penetration Affecting Growth 16
3.4.2.3 Device Recalls Negatively Affect Physician and Patient Perceptions 16
3.5 Glucose Monitoring Systems: Perception Analysis 17
3.6 Glucose Monitoring Systems: Opportunities and Unmet Need 18
3.6.1 Major Unmet Needs 20
3.7 Key Takeaway 20
4 Global Glucose Monitoring Systems Market : Competitive Assessment 21
4.1 Overview 21
4.2 Strategic Competitor Assessment 21
4.3 Glucose Monitoring Systems Company Shares 2008 23
4.4 F. Hoffmann-La Roche Ltd 24
4.4.1 Diabetes Educational Programs by Roche 24
4.5 LifeScan (Johnson & Johnson) 24
4.5.1 Diabetes Educational Programs by Johnson & Johnson 25
4.6 Bayer Healthcare 25
4.6.1 Diabetes Educational Programs by Bayer Healthcare 25
4.7 Abbott Laboratories 26
4.7.1 Diabetes Educational programs by Abbott Labs 26
4.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market 27
4.8.1 Accu-Check Aviva 27
4.8.1.1 Overview 27
4.8.1.2 Efficacy 27
4.8.1.3 Safety Profile 27
4.8.1.4 Pricing 27
4.8.1.5 Clinical Trial Details 27
4.8.2 OneTouch Ultramini 28
4.8.2.1 Overview 28
4.8.2.2 Efficacy 28
4.8.2.3 Safety 28
4.8.2.4 Pricing 29
4.8.3 Contour Meter 29
4.8.3.1 Overview 29
4.8.3.2 Efficacy 29
4.8.3.3 Safety 29
4.8.3.4 Pricing 29
4.9 Key Takeaway 30
5 Global Glucose Monitoring Systems Market: Pipeline Assessment 31
5.1 Overview 31
5.2 Strategic Pipeline Assessment 31
5.3 Glucose Monitoring Systems – Pipeline by Clinical Phase of Development 34
5.4 Profiles of Promising Devices under Clinical Development 35
5.4.1 EyeSense Blood glucose measurement device 35
5.4.1.1 Overview 35
5.4.1.2 Efficacy 35
5.4.1.3 Safety 35
5.4.1.4 Clinical Study Detail 35
5.4.2 GlucoTrack 36
5.4.2.1 Overview 36
5.4.2.2 Efficacy 36
5.4.2.3 Safety 36
5.4.2.4 Clinical Study Details 36
5.4.3 LighTouch Monitor 37
5.4.3.1 Overview 37
5.4.3.2 Efficacy 37
5.4.3.3 Safety 37
5.5 Glucose Monitoring Systems Market: List of Pipeline Products 38
5.6 Glucose Monitoring Systems Pipeline Product Summary by Product Type 41
5.7 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems 42
5.8 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems 44
5.9 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems 45
5.10 Key Takeaway 45
6 Global Glucose Monitoring Systems Market : Implications for Future Market Competition 46
6.1 Strategic Competitor Assessment 47
7 Global Glucose Monitoring Systems Market: Emerging Companies 48
7.1 Introduction 48
8 Appendix 50
8.1 Definitions 50
8.1.1 Glucose Monitoring 50
8.1.1.1 Blood Glucose Meters 50
8.1.1.2 Blood Glucose Test Strips 50
8.2 Research Methodology 51
8.3 Secondary Research 52
8.4 Primary Research 52
8.5 Models 53
8.6 Forecasts 53
8.7 Expert Panels 53
8.8 GlobalData Consulting 54
8.9 Contact Us 54
8.10 Disclaimer 54